Stocks and Investing
Stocks and Investing
Thu, August 8, 2024
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
Joseph Stringer Reiterated (STOK) at Strong Buy and Held Target at $22 on, Aug 8th, 2024
Joseph Stringer of Needham, Reiterated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $22 on, Aug 8th, 2024.
Joseph has made no other calls on STOK in the last 4 months.
There are 3 other peers that have a rating on STOK. Out of the 3 peers that are also analyzing STOK, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Joseph
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $17 on, Thursday, July 11th, 2024
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, May 7th, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Tuesday, May 7th, 2024
Contributing Sources